|
Volumn 37, Issue 1, 1995, Pages 30-40
|
Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
a,c b b a,c b b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
METHOTREXATE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FUNCTIONAL ASSESSMENT;
HEADACHE;
HUMAN;
MALE;
MOTOR PERFORMANCE;
MULTIPLE SCLEROSIS;
MYALGIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TASK PERFORMANCE;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
CHRONIC DISEASE;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
IMMUNOSUPPRESSION;
MALE;
METHOTREXATE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0028906384
PISSN: 03645134
EISSN: 15318249
Source Type: Journal
DOI: 10.1002/ana.410370108 Document Type: Article |
Times cited : (319)
|
References (50)
|